North Crest Asset Manangement, LLC Ocugen, Inc. Transaction History
North Crest Asset Manangement, LLC
- $3.19 Billion
- Q4 2024
A detailed history of North Crest Asset Manangement, LLC transactions in Ocugen, Inc. stock. As of the latest transaction made, North Crest Asset Manangement, LLC holds 90,780 shares of OCGN stock, worth $70,808. This represents 0.0% of its overall portfolio holdings.
Number of Shares
90,780
Previous 90,780
-0.0%
Holding current value
$70,808
Previous $89,000
19.1%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding OCGN
# of Institutions
123Shares Held
78.3MCall Options Held
535KPut Options Held
523K-
Black Rock Inc. New York, NY17.9MShares$14 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.9MShares$13.2 Million0.0% of portfolio
-
State Street Corp Boston, MA15.8MShares$12.3 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA6.28MShares$4.9 Million0.0% of portfolio
-
Gmt Capital Corp Atlanta, GA2.45MShares$1.91 Million0.1% of portfolio
About Ocugen, Inc.
- Ticker OCGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 216,566,000
- Market Cap $169M
- Description
- Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...